Table 3.
Nanomaterials class | Nanomaterials name | Nanomaterials properties | Peptide | Biological effect | Effect on amyloidosis | Mode of interaction | Year | Ref. |
---|---|---|---|---|---|---|---|---|
Inorganic nanomaterials | Nanoceria | Size: 3–8 nm | Aβ25–35 | •Accumulate at mitochondrial outer membrane and plasma membrane •Reduce mitochondrial fragmentation •Reduce neuronal cell death |
Block Aβ-mediated mitochondrial fragmentation via the reduction of DRP1 S616 hyperphosphorylation | 2014 | [157] | |
SPIONs-PEG-NH2 | Size: 20 nm Surface charge: 17.4 ± 2.5 mV |
Aβ42 | Dual effects on Aβ fibrillization: •High concentrations accelerate fibrillization under magnetic field •Lower concentrations inhibit fibrillization under magnetic field |
Magnetic field on the size and surface charge of SPIONs, thereby impacting Aβ fibrillization | 2015 | [156] | ||
AuNPs | Size: 20, 50 and 80 nm | Aβ | Aβ oligomers more toxic than Aβ fibrils or plaques in inducing acute cell death | •Aβ aggregates on nanoparticle surfaces •Larger particles induce more Aβ aggregation on particle surfaces with a shortened lag phase |
2015 | [149] | ||
Surface charge: positive (amine-AuNPs), negative (citrate-AuNPs) | Aβ | •Amine-AuNPs are more strongly attracted to Aβ, forming smaller aggregates, not protofibrils •Citrate-AuNPs act as nucleation seeds to accelerate fibrillization |
•Electrostatic interactions •Replacement of citrate on AuNPs with Aβ and direct attachment of AuNPs to Aβ |
|||||
Shape: Spherical AuNPs, nanorods (AuNRs), and nanocubes (AuNCs) | Aβ | Nanostructure-dependent cytotoxicity on neuroblastoma cells | •AuNCs interact with Aβ to produce fibril networks •AuNRs inhibit Aβ aggregation |
•AuNCs possess a larger effective surface area and are more isotropic than AuNRs •Larger aggregates form on AuNCs | ||||
CeONP@POMs | Size: ~5 nm Surface charge: −48.2 mV |
Aβ40 | •Reduce intracellular ROS •Promote PC12 cell proliferation •Cross the BBB •Inhibit Aβ-induced BV2 microglial cell activation |
•Inhibit Aβ fibrillization •Disaggregate peptide fibrils •Hydrolyze peptide monomers |
Hydrolytic effect | 2016 | [151] | |
MoS2 NPs | Size: ~100 nm FTIR peaks: 1630, 1420, and 1280 cm−1 |
Aβ42 | •Scavenge ROS •Block formation of Ca2+ channel in cell membrane •Alleviate cell toxicity |
•Inhibit Aβ fibrillization •Destabilize Aβ fibrils |
Electrostatic attraction and high surface ratio effects | 2017 | [150] | |
CGA@SeNPs | Size: ~100 nm | Aβ40 | •Reduce ROS generation •Inhibit neurotoxicity of Aβ40 |
Inhibit Aβ aggregation | Aβ binds on SeNPs via N-donors containing side chains of amino acids to form an Se–N bond, blocking direct contact between peptide monomers | 2018 | [155] | |
βCas AuNPs | Size: 7.5 ± 2.6 nm Surface charge: −11.7 ± 1.8 mV |
Aβ42 | •No lethality but reduced locomotion, nonresponsive mobility and a loss of balance in larvae upon Aβ injection •βCas AuNPs recover the mobility and cognitive function of adult zebrafish |
•No such mitigation is obtained with caseins alone •βCas promote fast Aβ nucleation |
Sequester toxic Aβ42 through a nonspecific, chaperone-like manner | 2019 | [24] | |
SiO2–cyclen | Size: 65.2 ± 4.9 nm | Aβ40 | •Cross the BBB •Reduce cytotoxicity and ROS |
Inhibit metal-induced aggregation (Zn2+, Cu2+) | •Metal-chelation •Crossing the BBB via adsorptive or receptor-mediated transportation |
2019 | [154] | |
BP@BTA | Height: 3–5 nm UV–vis: 345 nm (BTA, covalent interaction with BP) |
Aβ42 | •Reduce the peptide cytotoxicity •Attenuate peptide neurotoxicity to CL2006, extend the lifespan of worms •BP@BTA and its degradation products are nontoxic and biocompatible |
•Inhibit Aβ aggregation under NIR, no effect under dark •Oxygenate Aβ |
High affinity for Aβ due to specific amyloid selectivity of BTA | 2019 | [153] | |
AgTNPs | Edge length: 70 ± 8 nm Surface charge: −41 ± 1.4 mV |
Aβ40 | Increase cell viability | •Prevent formation of Aβ fibrils •Dissolve mature Aβ fibrils |
•AgTNPs selective bind the positively charged amyloidogenic sequence of Aβ monomer •AgTNPs dissolve mature Aβ fibrils via plasmonic photothermal property |
2019 | [152] | |
Polymeric nanomaterials | PMA-nanodiscs | Size: ~10 nm | Aβ40 | Aβ40 oligomers incubated with PMA-nanodiscs exhibit relatively less neurotoxic and neuronal damage | •Lipid concentration and composition are important to regulate Aβ fibrillization •Form low-ordered Aβ aggregates in the presence of nanodiscs |
Amide (H–N) and side chain protons of Aβ show a correlation with PMA functional groups, hydrophobic chain and quaternary ammonium group | 2018 | [159] |
NC-KLVFF | Size: 14 ± 4 nm | Aβ42 | •Attenuate neuron damage •Regain endocranial microglia’s capability to phagocytose Aβ •Protect hippocampal neurons against Apoptosis |
•Inhibit self-aggregation of Aβ •Dissociate Aβ fibrils |
•Polymeric surface property impacts peptide binding affinity •Block interaction between Aβ oligomers and cell membranes |
2019 | [22] | |
CPNPs | Size: ~4.7 nm Surface charge: ~ 30 mV |
Aβ40 | Inhibit Aβ fibrillization | Binding to the termini of seed fibrils can effectively inhibit fibrillization | 2019 | [165] | ||
G5-PAMAM G6-PAMAM | NMR: 7.05–7.25 ppm UV peak: 260 nm |
Aβ42 | Phenyl derivatives of high-generation dendrimers (G5-P and G6-P) significantly inhibit Aβ42 aggregation and alter ultrastructure of Aβ42 aggregates | Hydrophobic binding-electrostatic repulsion theory | 2019 | [160] | ||
Carbon-based nanomaterials | GQDs | Size: ~8 nm Surface charge: negative |
Aβ42 | •Increase survival rate •Great biocompatibility |
Inhibit Aβ fibrillization | Hydrophobic and electrostatic interactions | 2015 | [166] |
C60(OH)16 | Aβ40 | Biocompatible materials | •Reduce the formation of amyloid fibrils | •Electrostatic interactions •Binding with hydrophobic Aβ C-terminus |
2016 | [167] | ||
SWNT-OH | Size: ~8 nm | Aβ42 | Cytoprotective effects against Aβ42 fibrillization-induced cytotoxicity | •Inhibit Aβ42 fibrillization •Disaggregate preformed amyloid fibrils |
Nonpolar interactions, especially van der Waals forces | 2019 | [168] | |
CQDs | Size: ~2.8 nm Surface charge: ~−44.6 mV |
Aβ42 | Restore embryo survival rate by 32% Decrease ROS production | Inhibit Aβ fibrillization | Hydrophobic interaction and H-bonding | 2020 | [138] | |
Biologically inspired nanomaterials | ApoE3-rHDL nanodiscs | Size: 27.9 ± 8.9 nm Surface charge: −4.07 ± 0.83 mV |
Aβ40, Aβ42 | •Accelerate microglial, astroglial, and liver cell degradation of Aβ by facilitating lysosomal transport •Cross the BBB |
Inhibit Aβ aggregation | •Receptor-mediated endocytosis •High binding affinity for Aβ monomers and oligomers |
2014 | [162] |
αNAP-GM1-rHDL | Size: 25.42 ± 1.18 nm Surface charge: −15.70 ± 0.93 mV |
Aβ42 | •Decrease cell toxicity in vitro •Reduce Aβ deposition, ameliorate neurologic changes, and rescue memory loss in vivo |
•Inhibit Aβ aggregation •High Aβ binding affinity and clearance activity |
•Aβ targeting: GM1 •ApoE-concentration-dependent binding synergetic effect of DMPC, GM1 and ApoE |
2015 | [163] | |
ANC-α-M | Size: 35.95 ± 9.05 nm Surface charge: negative |
Aβ42 | •Accelerate Aβ42 degradation •Facilitate microglia-mediated uptake in vitro •Decrease amyloid deposition, attenuate microgliosis, and rescue memory deficit in AD mice |
Block formation of both Aβ oligomers and fibrils, disturb preformed fibrils | •High affinity for Aβ monomers and oligomers •ApoE-dependent cellular uptake |
2016 | [161] | |
dcHGT NPs | Size: ~15 nm | Aβ42 | •Relieve inflammation and protect primary neurons from Aβ oligomer-induced neurotoxicity in vitro •Reduce Aβ deposition, ameliorate neuron morphological changes, rescue memory deficits, and improve acetylcholine regulation ability in vivo |
Inhibit and eliminate Aβ aggregation | •Aβ targeting-GM 1 •Metal-ion chelation and inhibition of AChE activity |
2020 | [164] |